IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q1 2023 Holdings

Filed 2023-05-12 | 14 holdings | $88.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$30.1M6,950,00034.0%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$12.4M722,08014.0%
Invivyd Inc(IVVD)COM00534A102$11.1M9,248,25012.5%
TG Therapeutics Inc(TGTX)COM88322Q108$5.1M339,5005.8%
Springworks Therapeutics IncCOM85205L107$5.1M197,7005.8%
Bridgebio Pharma Inc(BBIO)COM10806X102$5.1M304,7005.7%
Ionis Pharmaceuticals Inc(IONS)COM462222100$4.5M126,3005.1%
Stoke Therapeutics Inc(STOK)COM86150R107$4.4M532,8905.0%
Proqr Thrapeutics N VSHS EURON71542109$4.1M1,910,6004.6%
Curis Inc(CRISEUR)COM NEW231269200$2.7M4,482,1423.0%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$1.7M67,4001.9%
Atara Biotherapeutics Inc(ATRAGBX)COM046513107$1.3M439,3001.4%
Silence Therapeutics PLC(SLN)ADS82686Q101$904.6K145,9001.0%
Neximmune IncCOM65344D109$50.7K133,4420.1%